Skip to menu Skip to content Skip to footer

2023

Conference Publication

A High-grade Gliomas Occurring In Teenagers And Young Adult Patients Comprise Novel Molecular Subgroups

Clarke, M. T., Pereira, R., Mackay, A., Grabovska, Y., Clarke, A., Nicoll, J., Procter, J., Moore, A., Schagen, J., Walker, L., Roncaroli, F., Ogunbigi, O., Jacques, T., Marshall, L., Carceller, F., Reisz, Z., Al-Sarraj, S., Vinci, M., Kurian, K., Ng, H., Brandner, S. and Jones, C. (2023). A High-grade Gliomas Occurring In Teenagers And Young Adult Patients Comprise Novel Molecular Subgroups. 18th Meeting of the European Association of Neuro-Oncology, Rotterdam, Netherlands, 21-24 September 2023. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/neuonc/noad137.069

A High-grade Gliomas Occurring In Teenagers And Young Adult Patients Comprise Novel Molecular Subgroups

2023

Conference Publication

High-grade gliomas occurring in teenagers and young adult patients comprise novel molecular subgroups

Clarke, Matthew, Pereira, Rita, Mackay, Alan, Grabovska, Yura, Clarke, Amelia, Nicoll, James, Procter, John, Moore, Andrew, Schagen, Joanna, Walker, Liam, Roncaroli, Federico, Ogunbigi, Olumide, Jacques, Thomas, Marshall, Lynley, Carceller, Fernando, Reisz, Zita, Al-Sarraj, Safa, Vinci, Maria, Kurian, Kathreena, Ng, H K, Brandner, Sebastian and Jones, Chris (2023). High-grade gliomas occurring in teenagers and young adult patients comprise novel molecular subgroups. 2023 Pediatric Neuro-Oncology Research Conference, Washington, DC United States, 22-24 June 2023. Cary, NC United States: Oxford University Press. doi: 10.1093/neuonc/noad073.164

High-grade gliomas occurring in teenagers and young adult patients comprise novel molecular subgroups

2018

Conference Publication

Diffuse intrinsic pontine glioma and pediatric glioblastoma derived-exosomes have specific oncogenic signatures

Pericoli, Giulia, Galardi, Angela, Petrilli, Lucia Lisa, Colletti, Marta, Ferretti, Roberta, Paolini, Alessandro, Masotti, Andrea, Mortera, Stefano Levi, Petrini, Stefania, de Billy, Emmanuel, Pascucci, Luisa, Court, Will, Cacchione, Antonella, Carai, Andrea, Camassei, Francesca Diomedi, Moore, Andrew, Carcaboso, Angel Montero, Jones, Chris, Mastronuzzi, Angela, Locatelli, Franco, Di Giannatale, Angela and Vinci, Maria (2018). Diffuse intrinsic pontine glioma and pediatric glioblastoma derived-exosomes have specific oncogenic signatures. 23rd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd CNS Anticancer Drug Discovery and Development Conference, New Orleans, LA, United States, 14-18 November 2018. Cary, NC, United States: Oxford University Press.

Diffuse intrinsic pontine glioma and pediatric glioblastoma derived-exosomes have specific oncogenic signatures

2018

Conference Publication

Targeting H3.3G34R/V re-wiring of the epigenome in paediatric glioblastoma of children and young adults

Bjerke, Lynn, Mackay, Alan, Carvalho, Diana, Pemberton, Helen, Molinari, Valeria, Vinci, Maria, Carceller, Fernando, Marshall, Lynley, Moore, Andrew, Montero Carcaboso, Angel, Lord, Chris, Hargrave, Darren and Jones, Chris (2018). Targeting H3.3G34R/V re-wiring of the epigenome in paediatric glioblastoma of children and young adults. 23rd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd CNS Anticancer Drug Discovery and Development Conference, New Orleans, United States, 14-18 November, 2018. Cary, NC, United States: Oxford University Press.

Targeting H3.3G34R/V re-wiring of the epigenome in paediatric glioblastoma of children and young adults

2018

Conference Publication

Aberrant splicing of KMT2A as a potential molecular MRD marker in cytogenetically-normal AML

Zhang, Christine R. C., Afrin, Sadia, Maybury, Mellissa, Pham, Thy, Fink, Lynn and Moore, Andrew S. (2018). Aberrant splicing of KMT2A as a potential molecular MRD marker in cytogenetically-normal AML. 60th Annual Meeting of the American Society of Hematology (ASH), San Diego, CA USA, 1-4 December 2018. Washington, DC USA: American Society of Hematology. doi: 10.1182/blood-2018-99-117759

Aberrant splicing of KMT2A as a potential molecular MRD marker in cytogenetically-normal AML

2018

Conference Publication

The Molecular Pathology of Infant Gliomas

Clarke, M. T., Jones, D., Carvalho, D. M., Mackay, A., Izquierdo, E., Hargrave, D., Moore, A. S., Popov, S., Jacques, T. S. and Jones, C. (2018). The Molecular Pathology of Infant Gliomas. Winter Meeting on Epigenetics - Understanding Disease and Guiding Therapies / Joint Meeting of the Royal-Society-of-Medicine / 209th Scientific Meeting of the Pathological-Society-of-Great-Britain-and-Ireland, Marylebone England, 25-26 January 2018. Hoboken, NJ United States: Wiley.

The Molecular Pathology of Infant Gliomas

2018

Conference Publication

Quantitative analysis of MLL fusion transcripts by droplet digital PCR to monitor minimal residual disease in MLL-rearranged acute myeloid leukemia

Afrin, Sadia, Zhang, Christine R. C., Meyer, Claus, Maybury, Mellissa, Pham, Thy, Venn, Nicola, Trahair, Toby N., Sutton, Rosemary, Marschalek, Rolf, Fink, Lynn and Moore, Andrew S. (2018). Quantitative analysis of MLL fusion transcripts by droplet digital PCR to monitor minimal residual disease in MLL-rearranged acute myeloid leukemia. 60th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA USA, 1-4 December 2018. Washington, DC USA: American Society of Hematology. doi: 10.1182/blood-2018-99-117761

Quantitative analysis of MLL fusion transcripts by droplet digital PCR to monitor minimal residual disease in MLL-rearranged acute myeloid leukemia

2018

Conference Publication

The molecular pathology of infant gliomas

Clarke, M., Jones, D. T. W., Carvalho, D., Mackay, A., Izquierdo, E., Hargrave, D., Moore, A. S., Popov, S., Jacques, T. and Jones, C. (2018). The molecular pathology of infant gliomas. 119th Meeting of the British-Neuropathological-Society (BNS) / Epilepsy Neuropathology Symposium, London England, Feb 28-Mar 02 2018. Hoboken, NJ United States: Wiley.

The molecular pathology of infant gliomas

2016

Conference Publication

A pilot study to investigate the relationship between doxorubicin and doxorubicinol pharmacokinetics and cardiotoxicity in children and adolescents with cancer.

Hennig, S., Kunarajah, K., Norris, R., Lobb, M., Charles, B., Pinkerton, R. and Moore, A. S. (2016). A pilot study to investigate the relationship between doxorubicin and doxorubicinol pharmacokinetics and cardiotoxicity in children and adolescents with cancer.. World Conference of Pharmacometrics, Brisbane / Brisbane Convention Centre, 21-24 August 2016.

A pilot study to investigate the relationship between doxorubicin and doxorubicinol pharmacokinetics and cardiotoxicity in children and adolescents with cancer.

2015

Conference Publication

Rare and Common Germline Variants Contribute to Occurrence of Myelodysplastic Syndrome

Hahn, Christopher N., Babic, Milena, Schreiber, Andreas W., Kutyna, Monika M., Wee, L. Amilia, Brown, Anna L., Perugini, Michelle, Singhal, Deepak, Hiwase, Smita, Feng, Jinghua, Parker, Wendy T., Moore, Sarah, Bardy, Peter G., Saal, Russell, Marlton, Paula, Moore, Andrew S., Gonda, Thomas J., Leo, Paul, Branford, Susan, DAndrea, Richard J., Lewis, Ian D., Bik, Luen, Scott, Harnish S. and Hiwase, Devendra (2015). Rare and Common Germline Variants Contribute to Occurrence of Myelodysplastic Syndrome. 57th Annual Meeting of the American-Society-of-Hematology, Orlando, FL, United States, 5-8 December 2015. WASHINGTON: AMER SOC HEMATOLOGY. doi: 10.1182/blood.V126.23.1644.1644

Rare and Common Germline Variants Contribute to Occurrence of Myelodysplastic Syndrome

2014

Conference Publication

Inhibition of Telomerase with Imetelstat Is Detrimental to Leukemia Stem Cells in Acute Myeloid Leukemia (AML)

Bruedigam, Claudia, Bagger, Frederik Otzen, Heidel, Florian H., Kuhn, Catherine, Guignes, Solene, Song, Axia, Austin, Rebecca, Vu, Therese, Lee, Erwin M., Moore, Andrew S., Lock, Richard B., Bullinger, Lars, Hill, Geoff R. and Lane, Steven W. (2014). Inhibition of Telomerase with Imetelstat Is Detrimental to Leukemia Stem Cells in Acute Myeloid Leukemia (AML). 56th Annual Meeting of the American Society of Hematology, San Francisco CA, United States, 06-09 December 2014. Washington, DC United States: American Society of Hematology.

Inhibition of Telomerase with Imetelstat Is Detrimental to Leukemia Stem Cells in Acute Myeloid Leukemia (AML)

2011

Conference Publication

Blood collection technique for pharmacokinetic studies of doxorubicin in paediatric patients

Lobb, M., Norris, R. L. G., Charles, B., Gilshenan, K., Moore, A. and Pinkerton, R. (2011). Blood collection technique for pharmacokinetic studies of doxorubicin in paediatric patients. 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Stuttgart, Germany, 2-6 October, 2011. Philadelphia PA, United States: Lippincott Wiliams & Wilkins. doi: 10.1097/01.ftd.0000400651.94145.ba

Blood collection technique for pharmacokinetic studies of doxorubicin in paediatric patients

2011

Conference Publication

Resistance to Selective FLT3 Inhibitors, Driven by FLT3 Ligand and FLT3 Point Mutations, Can Be Overcome with the Dual FLT3-Aurora Kinase Inhibitor CCT241736

Moore, AS, Faisal, A, Bavetsias, V, de Castro, DG, Sun, CB, Atrash, B, Valenti, M, Brandon, AD, Avery, S, Pearson, ADJ, Workman, P, Blagg, J, Raynaud, FI, Eccles, SA and Linardopoulos, S (2011). Resistance to Selective FLT3 Inhibitors, Driven by FLT3 Ligand and FLT3 Point Mutations, Can Be Overcome with the Dual FLT3-Aurora Kinase Inhibitor CCT241736. 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), San Diego CA, DEC 10-13, 2011.

Resistance to Selective FLT3 Inhibitors, Driven by FLT3 Ligand and FLT3 Point Mutations, Can Be Overcome with the Dual FLT3-Aurora Kinase Inhibitor CCT241736

2010

Conference Publication

Dual Inhibition of Aurora and FLT3 Kinases by CCT137690: A Novel Treatment Strategy Against FLT3-ITD Positive AML In Vitro and In Vivo

Moore, AS, Faisal, A, Bavetsias, V, Sun, CB, Atrash, B, Valenti, M, Brandon, AD, Avery, S, Raynaud, FI, Workman, P, Pearson, ADJ, Blagg, J, Eccles, SA and Linardopoulos, S (2010). Dual Inhibition of Aurora and FLT3 Kinases by CCT137690: A Novel Treatment Strategy Against FLT3-ITD Positive AML In Vitro and In Vivo. 52nd Annual Meeting of the American-Society-of-Hematology (ASH), Orlando FL, DEC 04-07, 2010.

Dual Inhibition of Aurora and FLT3 Kinases by CCT137690: A Novel Treatment Strategy Against FLT3-ITD Positive AML In Vitro and In Vivo

2010

Conference Publication

Adaptation and Validation of the Plasma Inhibitory Activity (PIA) Assay to Detect Inhibition of Aurora, ABL and FLT3 kinases by AT9283 In Children and Adolescents with Leukaemia.

Podesta, JE, Griffin, MJ, Sugar, R, Squires, MS, Boddy, A, Linardopoulos, S, Pearson, ADJ and Moore, AS (2010). Adaptation and Validation of the Plasma Inhibitory Activity (PIA) Assay to Detect Inhibition of Aurora, ABL and FLT3 kinases by AT9283 In Children and Adolescents with Leukaemia.. 52nd Annual Meeting of the American-Society-of-Hematology (ASH), Orlando FL, DEC 04-07, 2010.

Adaptation and Validation of the Plasma Inhibitory Activity (PIA) Assay to Detect Inhibition of Aurora, ABL and FLT3 kinases by AT9283 In Children and Adolescents with Leukaemia.

2008

Conference Publication

Use of etanercept in children following haematopoietic stem cell transplantation: a single institution experience

Moore, A.S. and Hallahan, A.R. (2008). Use of etanercept in children following haematopoietic stem cell transplantation: a single institution experience. 48th Annual Scientific Meeting of the British Society for Haematology, Glasgow, Scotland, 7-9 April 2008. United Kingdom: Wiley-Blackwell Publishing Ltd.. doi: 10.1111/j.1365-2141.2008.07061.x

Use of etanercept in children following haematopoietic stem cell transplantation: a single institution experience

2007

Conference Publication

Does myelosuppression during consolidation or high-dose methotrexate clearance correlate with tolerance of initial maintenance therapy in childhood acute lymphoblastic leukaemia?

Moore, Andrew, Charles, Bruce, Wilkinson, Catherine, Weier, Steven and Pinkerton, Ross (2007). Does myelosuppression during consolidation or high-dose methotrexate clearance correlate with tolerance of initial maintenance therapy in childhood acute lymphoblastic leukaemia?. 39th Annual Conference of the International Society of Paediatric Oncology SIOP 2007, Mumbai, India, 31 October-3 November 2007. Hoboken: Wiley-Liss, Inc. doi: 10.1002/pbc.21342

Does myelosuppression during consolidation or high-dose methotrexate clearance correlate with tolerance of initial maintenance therapy in childhood acute lymphoblastic leukaemia?